✍️ 🧑‍🦱 💚 Autor:innen verdienen bei uns doppelt. Dank euch haben sie so schon 388.554 € mehr verdient. → Mehr erfahren 💪 📚 🙏

Sulfasalazine/sorafenib: A novel antitumor combination therapy for HCC

Sulfasalazine/sorafenib: A novel antitumor combination therapy for HCC

von Maged Wasfy und Marium Shamaa
Softcover - 9783330859548
35,90 €
  • Versandkostenfrei
Auf meine Merkliste
  • Hinweis: Print on Demand. Lieferbar in 2 Tagen.
  • Lieferzeit nach Versand: ca. 1-2 Tage
  • inkl. MwSt. & Versandkosten (innerhalb Deutschlands)

Autorenfreundlich Bücher kaufen?!

Beschreibung

Hepatocellular carcinoma (HCC) is a frequent and deadly human disease. The management of HCC has substantially changed in the past few decades. In recent decades, tremendous progress has been made toward better understanding the molecular mechanisms of oncogenic processes. Hepatocarcinogenesis is a very complex system of pathways and results from genetic alterations affecting many cellular signaling cascades. This book,therefore, provides a new metric of success for HCC treatment. Till now there is no gold standard treatment for HCC. Sulfasalazine/sorafenib combination therapy: A new hope for HCC patients. Now you can beat your cancer.

Future prospectives

Details

Verlag Noor Publishing
Ersterscheinung April 2017
Maße 22 cm x 15 cm x 0.6 cm
Gewicht 149 Gramm
Format Softcover
ISBN-13 9783330859548
Seiten 88

Schlagwörter